United States Biotechnology & Medical Research

Emisphere Technologies Inc (EMIS)

Track

Ticker: EMIS Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Garone Michael Secretary, CFO Officer
Transaction date
Purchase
Price
71.79
Quantity 35,834 +43.6%
Value US$1,627,181
Garone Michael Secretary, CFO Officer
Transaction date
Purchase
Price
458.96
Quantity 33,643 -11.7%
Value US$3,351,570
Garone Michael Secretary, CFO Officer
Transaction date
Purchase
Price
181.75
Quantity 38,072 -11.3%
Value US$3,143,034
Garone Michael Secretary, CFO Officer
Transaction date
Purchase
Price
1.08
Quantity 2,500 +7.8%
Value US$2,700
Garone Michael Secretary, CFO Officer
Transaction date
Purchase
Price
1.10
Quantity 32,000 +inf%
Value US$35,200
Riley Gary VP, Nonclinical Dev & Appl Bio Officer
Transaction date
Sale
Price
0.70
Quantity 7,000 -25.5%
Value US$4,900
Riley Gary VP, Nonclinical Dev & Appl Bio Officer
Transaction date
Sale
Price
0.70
Quantity 5,000 -15.4%
Value US$3,500
Riley Gary VP, Nonclinical Dev & Appl Bio Officer
Transaction date
Sale
Price
0.71
Quantity 5,000 -13.3%
Value US$3,525
Riley Gary VP, Nonclinical Dev & Appl Bio Officer
Transaction date
Sale
Price
0.72
Quantity 5,000 -11.8%
Value US$3,600
Riley Gary VP, Nonclinical Dev & Appl Bio Officer
Transaction date
Sale
Price
0.74
Quantity 7,500 -15.0%
Value US$5,550
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.20
Quantity 14,744 +41.8%
Value US$61,925
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.19
Quantity 200 +0.6%
Value US$838
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.19
Quantity 100 +0.3%
Value US$418
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.18
Quantity 100 +0.3%
Value US$418
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.17
Quantity 737 +2.2%
Value US$3,073
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.16
Quantity 500 +1.5%
Value US$2,080
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.15
Quantity 6,000 +21.7%
Value US$24,900
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.14
Quantity 4,400 +18.9%
Value US$18,216
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.13
Quantity 300 +1.3%
Value US$1,239
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.11
Quantity 100 +0.4%
Value US$411
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.10
Quantity 400 +1.8%
Value US$1,640
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.09
Quantity 319 +1.4%
Value US$1,305
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.08
Quantity 200 +0.9%
Value US$816
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.07
Quantity 300 +1.4%
Value US$1,221
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.06
Quantity 1,600 +8.0%
Value US$6,496
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.20
Quantity 17,781 +801.3%
Value US$74,680
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.19
Quantity 719 +47.9%
Value US$3,013
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.18
Quantity 1,100 +275.0%
Value US$4,598
Riley Gary VP, Nonclinical Development Officer
Transaction date
Purchase
Price
4.17
Quantity 400 +inf%
Value US$1,668
Novinski Michael V President and CEO Executive Director
Transaction date
Purchase
Price
1.69
Quantity 1,300 +3.4%
Value US$2,197
Novinski Michael V President and CEO Executive Director
Transaction date
Purchase
Price
1.68
Quantity 3,900 +11.2%
Value US$6,552
Novinski Michael V President and CEO Executive Director
Transaction date
Purchase
Price
1.65
Quantity 4,700 +15.6%
Value US$7,755
Novinski Michael V President and CEO Executive Director
Transaction date
Purchase
Price
1.60
Quantity 2,200 +7.9%
Value US$3,520
Novinski Michael V President and CEO Executive Director
Transaction date
Purchase
Price
1.60
Quantity 1,968 +7.6%
Value US$3,149
Novinski Michael V President and CEO Executive Director
Transaction date
Purchase
Price
1.59
Quantity 800 +3.2%
Value US$1,272
Novinski Michael V President and CEO Executive Director
Transaction date
Purchase
Price
1.58
Quantity 132 +0.5%
Value US$209
Novinski Michael V President and CEO Officer
Transaction date
Purchase
Price
2.67
Quantity 5,000 +25.0%
Value US$13,336
GOLDBERG MICHAEL M Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 99,246
Value US$0
RACHESKY MARK H MD Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 129,390
Value US$0
RACHESKY MARK H MD Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.26
Quantity 473,577 +inf%
Value US$3,911,746
RACHESKY MARK H MD Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.26
Quantity 187,979 +inf%
Value US$1,552,707
RACHESKY MARK H MD Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.26
Quantity 31,554 +8.0%
Value US$260,636
RACHESKY MARK H MD Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.26
Quantity 266,890 +9.3%
Value US$2,204,511
BLACK MICHAEL E Non-Executive Director
Transaction date
Sale
Price
3.61
Quantity 500 -20.6%
Value US$1,805
BENDER LEWIS H Sr. VP Business Development
Transaction date
Sale
Price
5.18
Quantity 5,000 -26.4%
Value US$25,915
BENDER LEWIS H Sr. VP Business Development
Transaction date
Sale
Price
5.18
Quantity 103 -0.7%
Value US$534
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2010-09-17 2010-09-17 B Purchase Garone Michael

Secretary, CFO

Officer
35,834 +43.6%
71.79
US$1,627,181 		35,834 +43.6% 71.79 US$1,627,181
2010-09-17 2010-09-15 B Purchase Garone Michael

Secretary, CFO

Officer
33,643 -11.7%
458.96
US$3,351,570 		33,643 -11.7% 458.96 US$3,351,570
2010-09-17 2010-09-15 B Purchase Garone Michael

Secretary, CFO

Officer
38,072 -11.3%
181.75
US$3,143,034 		38,072 -11.3% 181.75 US$3,143,034
2010-09-17 2010-09-15 B Purchase Garone Michael

Secretary, CFO

Officer
2,500 +7.8%
1.08
US$2,700 		2,500 +7.8% 1.08 US$2,700
2010-09-17 2010-09-15 B Purchase Garone Michael

Secretary, CFO

Officer
32,000 +inf%
1.10
US$35,200 		32,000 +inf% 1.10 US$35,200
2009-12-10 2009-12-09 S Sale Riley Gary

VP, Nonclinical Dev & Appl Bio

Officer
7,000 -25.5%
0.70
US$4,900 		7,000 -25.5% 0.70 US$4,900
2009-12-10 2009-12-09 S Sale Riley Gary

VP, Nonclinical Dev & Appl Bio

Officer
5,000 -15.4%
0.70
US$3,500 		5,000 -15.4% 0.70 US$3,500
2009-12-10 2009-12-09 S Sale Riley Gary

VP, Nonclinical Dev & Appl Bio

Officer
5,000 -13.3%
0.71
US$3,525 		5,000 -13.3% 0.71 US$3,525
2009-12-10 2009-12-09 S Sale Riley Gary

VP, Nonclinical Dev & Appl Bio

Officer
5,000 -11.8%
0.72
US$3,600 		5,000 -11.8% 0.72 US$3,600
2009-12-10 2009-12-09 S Sale Riley Gary

VP, Nonclinical Dev & Appl Bio

Officer
7,500 -15.0%
0.74
US$5,550 		7,500 -15.0% 0.74 US$5,550
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
14,744 +41.8%
4.20
US$61,925 		14,744 +41.8% 4.20 US$61,925
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
200 +0.6%
4.19
US$838 		200 +0.6% 4.19 US$838
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
100 +0.3%
4.19
US$418 		100 +0.3% 4.19 US$418
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
100 +0.3%
4.18
US$418 		100 +0.3% 4.18 US$418
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
737 +2.2%
4.17
US$3,073 		737 +2.2% 4.17 US$3,073
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
500 +1.5%
4.16
US$2,080 		500 +1.5% 4.16 US$2,080
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
6,000 +21.7%
4.15
US$24,900 		6,000 +21.7% 4.15 US$24,900
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
4,400 +18.9%
4.14
US$18,216 		4,400 +18.9% 4.14 US$18,216
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
300 +1.3%
4.13
US$1,239 		300 +1.3% 4.13 US$1,239
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
100 +0.4%
4.11
US$411 		100 +0.4% 4.11 US$411
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
400 +1.8%
4.10
US$1,640 		400 +1.8% 4.10 US$1,640
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
319 +1.4%
4.09
US$1,305 		319 +1.4% 4.09 US$1,305
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
200 +0.9%
4.08
US$816 		200 +0.9% 4.08 US$816
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
300 +1.4%
4.07
US$1,221 		300 +1.4% 4.07 US$1,221
2008-08-20 2008-08-19 B Purchase Riley Gary

VP, Nonclinical Development

Officer
1,600 +8.0%
4.06
US$6,496 		1,600 +8.0% 4.06 US$6,496
2008-08-20 2008-08-18 B Purchase Riley Gary

VP, Nonclinical Development

Officer
17,781 +801.3%
4.20
US$74,680 		17,781 +801.3% 4.20 US$74,680
2008-08-20 2008-08-18 B Purchase Riley Gary

VP, Nonclinical Development

Officer
719 +47.9%
4.19
US$3,013 		719 +47.9% 4.19 US$3,013
2008-08-20 2008-08-18 B Purchase Riley Gary

VP, Nonclinical Development

Officer
1,100 +275.0%
4.18
US$4,598 		1,100 +275.0% 4.18 US$4,598
2008-08-20 2008-08-18 B Purchase Riley Gary

VP, Nonclinical Development

Officer
400 +inf%
4.17
US$1,668 		400 +inf% 4.17 US$1,668
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
1,300 +3.4%
1.69
US$2,197 		1,300 +3.4% 1.69 US$2,197
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
3,900 +11.2%
1.68
US$6,552 		3,900 +11.2% 1.68 US$6,552
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
4,700 +15.6%
1.65
US$7,755 		4,700 +15.6% 1.65 US$7,755
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
2,200 +7.9%
1.60
US$3,520 		2,200 +7.9% 1.60 US$3,520
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
1,968 +7.6%
1.60
US$3,149 		1,968 +7.6% 1.60 US$3,149
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
800 +3.2%
1.59
US$1,272 		800 +3.2% 1.59 US$1,272
2008-05-13 2008-05-09 B Purchase Novinski Michael V

President and CEO

Executive Director
132 +0.5%
1.58
US$209 		132 +0.5% 1.58 US$209
2007-12-31 2007-12-31 B Purchase Novinski Michael V

President and CEO

Officer
5,000 +25.0%
2.67
US$13,336 		5,000 +25.0% 2.67 US$13,336
2007-08-31 2007-08-22 B Purchase GOLDBERG MICHAEL M Non-Executive Director
99,246
0.00
US$0 		99,246 0.00 US$0
2007-08-24 2007-08-22 B Purchase RACHESKY MARK H MD Non-Executive Director Large shareholder
129,390
0.00
US$0 		129,390 0.00 US$0
2006-05-11 2006-05-09 B Purchase RACHESKY MARK H MD Non-Executive Director Large shareholder
473,577 +inf%
8.26
US$3,911,746 		473,577 +inf% 8.26 US$3,911,746
2006-05-11 2006-05-09 B Purchase RACHESKY MARK H MD Non-Executive Director Large shareholder
187,979 +inf%
8.26
US$1,552,707 		187,979 +inf% 8.26 US$1,552,707
2006-05-11 2006-05-09 B Purchase RACHESKY MARK H MD Non-Executive Director Large shareholder
31,554 +8.0%
8.26
US$260,636 		31,554 +8.0% 8.26 US$260,636
2006-05-11 2006-05-09 B Purchase RACHESKY MARK H MD Non-Executive Director Large shareholder
266,890 +9.3%
8.26
US$2,204,511 		266,890 +9.3% 8.26 US$2,204,511
2004-09-21 2004-09-16 S Sale BLACK MICHAEL E Non-Executive Director
500 -20.6%
3.61
US$1,805 		500 -20.6% 3.61 US$1,805
2004-05-11 2004-05-07 S Sale
BENDER LEWIS H

Sr. VP Business Development
5,000 -26.4%
5.18
US$25,915 		5,000 -26.4% 5.18 US$25,915
2004-05-11 2004-05-07 S Sale
BENDER LEWIS H

Sr. VP Business Development
103 -0.7%
5.18
US$534 		103 -0.7% 5.18 US$534
Explore more

More insider trading research around Emisphere Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America